3-Ethynylaniline CAS 54060-30-9 Tsarkake>99.0% (GC) Erlotinib Hydrochloride Intermediate
Jagoran masana'anta da mai siyar da Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis (2-Methoxyethoxy) -3H-Quinazolin-4-daya CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Sunan Sinadari | 3-Ethynylaniline |
Makamantu | 3-Aminophenylacetylene |
Lambar CAS | 54060-30-9 |
Lambar CAT | Saukewa: RF-PI2241 |
Matsayin Hannun jari | A cikin Hannun jari, Ƙarfin Ƙirƙirar 50MT/ Watan |
Tsarin kwayoyin halitta | C8H7N |
Nauyin Kwayoyin Halitta | 117.15 |
M | Mai Sauraron Iska, Mai Haske |
Wurin Tafasa | 120 ℃/20 mmHg |
Ruwan Solubility | Mara narkewa a cikin Ruwa |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Rawaya Mai Haske zuwa Ruwan Ruwa |
Tsarkake / Hanyar Bincike | > 99.0% (GC) |
Ruwa ta Karl Fischer | <0.50% |
Ragowa akan Ignition | <0.20% |
Jimlar ƙazanta | <1.00% |
Takamaiman Nauyi (20/20 ℃) | 1.041 ~ 1.048 |
Fihirisar Refractive n20/D | 1.614 ~ 1.6195 |
Infrared Spectrum | Yayi daidai da Tsarin |
Abubuwan da aka bayar na Proton NMR Spectrum | Yayi daidai da Tsarin |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin Magunguna;Erlotinib Hydrochloride Intermediate |
Kunshin: Fluorinated Bottle, 25kg/Drum, ko bisa ga abokin ciniki ta bukata
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi
3-Ethynylaniline, wanda kuma aka sani da 3-Aminophenylacetylene (CAS: 54060-30-9) ana amfani dashi azaman tsaka-tsakin magunguna.3-Ethynylaniline matsakaici ne na Erlotinib Hydrochloride (CAS: 183319-69-9).Erlotinib Hydrochloride ƙaramin ƙwayar ƙwayar ƙwayar cuta ce ta tyrosine kinase inhibitor wanda ke yin jujjuyawar akan masu karɓar girma na epidermal, hydrochloride na erlotinib, maganin da aka yi niyya na ƙwayoyin cuta.Hukumar Abinci da Magunguna ta Amurka (FDA) ta amince da erlotinib (Tarceva) tare da gemcitabine a matsayin jiyya ta farko don ci gaban gida da ciwon daji na pancreatic.Ana amfani da shi galibi azaman magani na layi na biyu ko na uku don ci gaba a cikin gida ko ciwon daji mara ƙarami (NSCLC) kuma azaman maganin kansar pancreatic.Ana amfani dashi azaman mai hana tyrosine don maganin NSCLC.Erlotinib Hydrochloride, quinazoline wanda aka samo ƙananan ƙwayoyin ƙwayoyin cuta na mai hana haɓakar haɓakar epidermal (EDGFR) tyrosine kinase, an amince dashi a watan Nuwamba, 2004, don maganin ci gaba ko ciwon daji mara ƙananan ƙwayar cuta.